Skip to main content
Top
Published in: Acta Neuropathologica Communications 1/2023

Open Access 01-12-2023 | Movement Disorder | Research

Movement disorders are linked to TDP-43 burden in the substantia nigra of FTLD-TDP brain donors

Authors: Luigi Fiondella, Priya Gami-Patel, Christian A. Blok, Annemieke J. M. Rozemuller, Jeroen J. M. Hoozemans, Yolande A. L. Pijnenburg, Marta Scarioni, Anke A. Dijkstra, The Netherlands Brain Bank

Published in: Acta Neuropathologica Communications | Issue 1/2023

Login to get access

Abstract

Movement disorders (MD) have been linked to degeneration of the substantia nigra (SN) in Parkinson’s disease and include bradykinesia, rigidity, and tremor. They are also present in frontotemporal dementia (FTD), where MD have been linked to frontotemporal lobar degeneration with tau pathology (FTLD-tau). Although MD can also occur in FTLD with TDP-43 pathology (FTLD-TDP), the local pathology in the SN of FTLD-TDP patients with MD is currently unexplored. The aims of this study are to characterize the frequency and the nature of MD in a cohort of FTLD-TDP brain donors and to investigate the relationship between the presence of MD, the nigral neuronal loss, and the TDP-43 burden in the SN. From our cohort of FTLD-TDP patients (n = 53), we included 13 donors who presented with MD (FTLD-MD+), and nine age-sex matched donors without MD (FTLD-MD-) for whom the SN was available. In these donors, the TDP-43 burden and the neuronal density in the SN were assessed with ImageJ and Qupath software. The results were compared between the two groups using T-test. We found that the TDP-43 burden in the SN was higher in FTLD-MD+ (mean 3,43%, SD ± 2,7) compared to FTLD-MD- (mean 1,21%, SD ± 0,67) (p = 0,04), while no significant difference in nigral neuronal density was found between the groups (p = 0,09). 17% of FTLD-TDP patients developed MD, which present as symmetric akinetic-rigid parkinsonism or CBS. Given the absence of a significant nigral neuronal cell loss, TDP-43 induced neuronal dysfunction could be sufficient to cause MD.
Literature
1.
go back to reference Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J et al (2011 Sep) Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134(9):2456–2477 Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J et al (2011 Sep) Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134(9):2456–2477
2.
go back to reference Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF et al Classification of primary progressive aphasia and its variants.Neurology. 2011 Mar15;76(11):1006–14 Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF et al Classification of primary progressive aphasia and its variants.Neurology. 2011 Mar15;76(11):1006–14
3.
go back to reference Forman MS, Farmer J, Johnson JK, Clark CM, Arnold SE, Coslett HB et al (2006 Jun) Frontotemporal dementia: clinicopathological correlations. Ann Neurol 59(6):952–962 Forman MS, Farmer J, Johnson JK, Clark CM, Arnold SE, Coslett HB et al (2006 Jun) Frontotemporal dementia: clinicopathological correlations. Ann Neurol 59(6):952–962
4.
go back to reference Espay AJ, Litvan I (2011 Nov) Parkinsonism and frontotemporal dementia: the clinical overlap. J Mol Neurosci MN 45(3):343–349 Espay AJ, Litvan I (2011 Nov) Parkinsonism and frontotemporal dementia: the clinical overlap. J Mol Neurosci MN 45(3):343–349
5.
go back to reference de Pablo-Fernández E, González-Herrero B, Cerdán Santacruz D, Rossor MN, Schott JM, Lashley T et al (2021 Mar) A clinicopathologic study of Movement Disorders in Frontotemporal Lobar Degeneration. Mov Disord Off J Mov Disord Soc 36(3):632–641 de Pablo-Fernández E, González-Herrero B, Cerdán Santacruz D, Rossor MN, Schott JM, Lashley T et al (2021 Mar) A clinicopathologic study of Movement Disorders in Frontotemporal Lobar Degeneration. Mov Disord Off J Mov Disord Soc 36(3):632–641
6.
go back to reference Baborie A, Griffiths TD, Jaros E, McKeith IG, Burn DJ, Richardson A et al (2011 Mar) Pathological correlates of frontotemporal lobar degeneration in the elderly. Acta Neuropathol (Berl) 121(3):365–371 Baborie A, Griffiths TD, Jaros E, McKeith IG, Burn DJ, Richardson A et al (2011 Mar) Pathological correlates of frontotemporal lobar degeneration in the elderly. Acta Neuropathol (Berl) 121(3):365–371
7.
go back to reference Scarioni M, Gami-Patel P, Timar Y, Seelaar H, van Swieten JC, Rozemuller AJM et al (2020 Jun) Frontotemporal Dementia: Correlations between Psychiatric symptoms and Pathology. Ann Neurol 87(6):950–961 Scarioni M, Gami-Patel P, Timar Y, Seelaar H, van Swieten JC, Rozemuller AJM et al (2020 Jun) Frontotemporal Dementia: Correlations between Psychiatric symptoms and Pathology. Ann Neurol 87(6):950–961
8.
go back to reference Park HK, Chung SJ (2013 May) New perspective on parkinsonism in frontotemporal lobar degeneration. J Mov Disord 6(1):1–8 Park HK, Chung SJ (2013 May) New perspective on parkinsonism in frontotemporal lobar degeneration. J Mov Disord 6(1):1–8
9.
go back to reference Foster NL, Wilhelmsen K, Sima AAF, Jones MZ, D’Amato CJ, Gilman S et al (1997) Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus conference. Ann Neurol. ;41(6):706–15 Foster NL, Wilhelmsen K, Sima AAF, Jones MZ, D’Amato CJ, Gilman S et al (1997) Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus conference. Ann Neurol. ;41(6):706–15
10.
go back to reference Hornykiewicz O (2008) Basic research on dopamine in Parkinson’s disease and the discovery of the nigrostriatal dopamine pathway: the view of an eyewitness. Neurodegener Dis 5(3–4):114–117CrossRefPubMed Hornykiewicz O (2008) Basic research on dopamine in Parkinson’s disease and the discovery of the nigrostriatal dopamine pathway: the view of an eyewitness. Neurodegener Dis 5(3–4):114–117CrossRefPubMed
11.
go back to reference Dijkstra AA, Voorn P, Berendse HW, Groenewegen HJ, Bank NB, Rozemuller AJM et al (2014 Sep) Stage-dependent nigral neuronal loss in incidental Lewy body and Parkinson’s disease. Mov Disord Off J Mov Disord Soc 29(10):1244–1251 Dijkstra AA, Voorn P, Berendse HW, Groenewegen HJ, Bank NB, Rozemuller AJM et al (2014 Sep) Stage-dependent nigral neuronal loss in incidental Lewy body and Parkinson’s disease. Mov Disord Off J Mov Disord Soc 29(10):1244–1251
12.
go back to reference Williams DR, Holton JL, Strand C, Pittman A, de Silva R, Lees AJ et al (2007 Jun) Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson’s syndrome. Brain J Neurol 130(Pt 6):1566–1576 Williams DR, Holton JL, Strand C, Pittman A, de Silva R, Lees AJ et al (2007 Jun) Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson’s syndrome. Brain J Neurol 130(Pt 6):1566–1576
13.
go back to reference Perry DC, Brown JA, Possin KL, Datta S, Trujillo A, Radke A et al (2017) Clinicopathological correlations in behavioural variant frontotemporal dementia. Brain J Neurol. Dec 1;140(12):3329–45 Perry DC, Brown JA, Possin KL, Datta S, Trujillo A, Radke A et al (2017) Clinicopathological correlations in behavioural variant frontotemporal dementia. Brain J Neurol. Dec 1;140(12):3329–45
15.
go back to reference Gibb WR, Lees AJ (1989 Feb) The significance of the Lewy body in the diagnosis of idiopathic Parkinson’s disease. Neuropathol Appl Neurobiol 15(1):27–44 Gibb WR, Lees AJ (1989 Feb) The significance of the Lewy body in the diagnosis of idiopathic Parkinson’s disease. Neuropathol Appl Neurobiol 15(1):27–44
16.
go back to reference Höglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE et al (2017 Jun) Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord Off J Mov Disord Soc 32(6):853–864 Höglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE et al (2017 Jun) Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord Off J Mov Disord Soc 32(6):853–864
17.
go back to reference Armstrong MJ, Litvan I, Lang AE, Bak TH, Bhatia KP, Borroni B et al (2013 Jan) Criteria for the diagnosis of corticobasal degeneration. Neurology 29(5):496–503 Armstrong MJ, Litvan I, Lang AE, Bak TH, Bhatia KP, Borroni B et al (2013 Jan) Criteria for the diagnosis of corticobasal degeneration. Neurology 29(5):496–503
18.
go back to reference Klioueva NM, Rademaker MC, Dexter DT, Al-Sarraj S, Seilhean D, Streichenberger N et al (1996) 2015 Jul;122(7):937–40 Klioueva NM, Rademaker MC, Dexter DT, Al-Sarraj S, Seilhean D, Streichenberger N et al (1996) 2015 Jul;122(7):937–40
19.
go back to reference World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.JAMA. 2013 Nov27;310(20):2191–4 World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.JAMA. 2013 Nov27;310(20):2191–4
21.
go back to reference Braak H, Del Tredici K, Rüb U, de Vos RAI, Jansen Steur ENH, Braak E (2003 Apr) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24(2):197–211 Braak H, Del Tredici K, Rüb U, de Vos RAI, Jansen Steur ENH, Braak E (2003 Apr) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24(2):197–211
22.
go back to reference Thal DR, Rüb U, Orantes M, Braak H Phases of Aβ-deposition in the human brain and its relevance for the development of AD.Neurology. 2002 Jun25;58(12):1791–800 Thal DR, Rüb U, Orantes M, Braak H Phases of Aβ-deposition in the human brain and its relevance for the development of AD.Neurology. 2002 Jun25;58(12):1791–800
23.
go back to reference Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006 Oct) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol (Berl) 112(4):389–404 Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006 Oct) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol (Berl) 112(4):389–404
24.
go back to reference Lee EB, Porta S, Michael Baer G, Xu Y, Suh E, Kwong LK et al (2017 Jul) Expansion of the classification of FTLD-TDP: distinct pathology associated with rapidly progressive frontotemporal degeneration. Acta Neuropathol (Berl) 134(1):65–78 Lee EB, Porta S, Michael Baer G, Xu Y, Suh E, Kwong LK et al (2017 Jul) Expansion of the classification of FTLD-TDP: distinct pathology associated with rapidly progressive frontotemporal degeneration. Acta Neuropathol (Berl) 134(1):65–78
25.
go back to reference Bankhead P, Loughrey MB, Fernández JA, Dombrowski Y, McArt DG, Dunne PD et al (2017 Dec) QuPath: open source software for digital pathology image analysis. Sci Rep 4:7:16878 Bankhead P, Loughrey MB, Fernández JA, Dombrowski Y, McArt DG, Dunne PD et al (2017 Dec) QuPath: open source software for digital pathology image analysis. Sci Rep 4:7:16878
26.
go back to reference Coulombe V, Saikali S, Goetz L, Takech MA, Philippe É, Parent A et al (2021) A Topographic Atlas of the human brainstem in the Ponto-Mesencephalic Junction Plane. Front Neuroanat 15:627656CrossRefPubMedPubMedCentral Coulombe V, Saikali S, Goetz L, Takech MA, Philippe É, Parent A et al (2021) A Topographic Atlas of the human brainstem in the Ponto-Mesencephalic Junction Plane. Front Neuroanat 15:627656CrossRefPubMedPubMedCentral
27.
go back to reference Scarioni M, Gami-Patel P, Peeters CFW, de Koning F, Seelaar H, Mol MO et al (2022) Psychiatric symptoms of frontotemporal dementia and subcortical (co-)pathology burden: new insights.Brain J Neurol. Feb 8;awac043. Scarioni M, Gami-Patel P, Peeters CFW, de Koning F, Seelaar H, Mol MO et al (2022) Psychiatric symptoms of frontotemporal dementia and subcortical (co-)pathology burden: new insights.Brain J Neurol. Feb 8;awac043.
28.
29.
go back to reference Knopman DS, Boeve BF, Parisi JE, Dickson DW, Smith GE, Ivnik RJ et al (2005 Apr) Antemortem diagnosis of frontotemporal lobar degeneration. Ann Neurol 57(4):480–488 Knopman DS, Boeve BF, Parisi JE, Dickson DW, Smith GE, Ivnik RJ et al (2005 Apr) Antemortem diagnosis of frontotemporal lobar degeneration. Ann Neurol 57(4):480–488
30.
go back to reference Josephs KA, Stroh A, Dugger B, Dickson DW (2009) Evaluation of subcortical pathology and clinical correlations in FTLD-U subtypes. Acta Neuropathol (Berl). Sep 1;118(3):349–58 Josephs KA, Stroh A, Dugger B, Dickson DW (2009) Evaluation of subcortical pathology and clinical correlations in FTLD-U subtypes. Acta Neuropathol (Berl). Sep 1;118(3):349–58
31.
go back to reference Mackenzie IR, Neumann M, Subcortical (2020 Jan) TDP-43 pathology patterns validate cortical FTLD-TDP subtypes and demonstrate unique aspects of C9orf72 mutation cases. Acta Neuropathol (Berl) 139(1):83–98 Mackenzie IR, Neumann M, Subcortical (2020 Jan) TDP-43 pathology patterns validate cortical FTLD-TDP subtypes and demonstrate unique aspects of C9orf72 mutation cases. Acta Neuropathol (Berl) 139(1):83–98
32.
go back to reference Tan RH, Kril JJ, Fatima M, McGeachie A, McCann H, Shepherd C et al (2015 Oct) TDP-43 proteinopathies: pathological identification of brain regions differentiating clinical phenotypes. Brain J Neurol 138(Pt 10):3110–3122 Tan RH, Kril JJ, Fatima M, McGeachie A, McCann H, Shepherd C et al (2015 Oct) TDP-43 proteinopathies: pathological identification of brain regions differentiating clinical phenotypes. Brain J Neurol 138(Pt 10):3110–3122
33.
go back to reference Liu Y, Stern Y, Chun MR, Jacobs DM, Yau P, Goldman JE (1997 Mar) Pathological correlates of extrapyramidal signs in Alzheimer’s disease. Ann Neurol 41(3):368–374 Liu Y, Stern Y, Chun MR, Jacobs DM, Yau P, Goldman JE (1997 Mar) Pathological correlates of extrapyramidal signs in Alzheimer’s disease. Ann Neurol 41(3):368–374
34.
go back to reference Schneider JA, Li J, Li Y, Wilson RS, Kordower JH, Bennett DA (2006 Jan) Substantia nigra tangles are related to gait impairment in older persons. Ann Neurol 59(1):166–173 Schneider JA, Li J, Li Y, Wilson RS, Kordower JH, Bennett DA (2006 Jan) Substantia nigra tangles are related to gait impairment in older persons. Ann Neurol 59(1):166–173
35.
go back to reference Park HK, Park KH, Yoon B, Lee JH, Choi SH, Joung JH et al Clinical characteristics of parkinsonism in frontotemporal dementia according to subtypes.J Neurol Sci. 2017 Jan15;372:51–6 Park HK, Park KH, Yoon B, Lee JH, Choi SH, Joung JH et al Clinical characteristics of parkinsonism in frontotemporal dementia according to subtypes.J Neurol Sci. 2017 Jan15;372:51–6
36.
go back to reference Gasca-Salas C, Masellis M, Khoo E, Shah BB, Fisman D, Lang AE et al (2016) Characterization of Movement Disorder Phenomenology in genetically proven, familial Frontotemporal Lobar Degeneration: a systematic review and Meta-analysis. PLoS ONE 11(4):e0153852CrossRefPubMedPubMedCentral Gasca-Salas C, Masellis M, Khoo E, Shah BB, Fisman D, Lang AE et al (2016) Characterization of Movement Disorder Phenomenology in genetically proven, familial Frontotemporal Lobar Degeneration: a systematic review and Meta-analysis. PLoS ONE 11(4):e0153852CrossRefPubMedPubMedCentral
Metadata
Title
Movement disorders are linked to TDP-43 burden in the substantia nigra of FTLD-TDP brain donors
Authors
Luigi Fiondella
Priya Gami-Patel
Christian A. Blok
Annemieke J. M. Rozemuller
Jeroen J. M. Hoozemans
Yolande A. L. Pijnenburg
Marta Scarioni
Anke A. Dijkstra
The Netherlands Brain Bank
Publication date
01-12-2023
Publisher
BioMed Central
Published in
Acta Neuropathologica Communications / Issue 1/2023
Electronic ISSN: 2051-5960
DOI
https://doi.org/10.1186/s40478-023-01560-7

Other articles of this Issue 1/2023

Acta Neuropathologica Communications 1/2023 Go to the issue